CardioDx, Inc.’s Leadership to Speak at the 5th Annual Personalized Medicine World Conference

CardioDx, Inc. announced today that President and CEO, David Levison, and Chief Medical Officer, Mark Monane, M.D., will present at the 5th Annual Personalized Medicine World Conference (PMWC) on Tuesday, January 29, 2013 in Mountain View, CA. Mr. Levison will provide a company perspective on the reimbursement pathway for molecular diagnostic tests, and Dr. Monane will present an overview of Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease.